Categories: Heart News, Scientific Conferences & Meetings

|

Published: October 31, 2022

Anti-clotting pill may spare kids from frequent injections, blood tests, dietary changes

American Heart Association Scientific Sessions 2022, Abstract 316

Related Images

Heart with artery view

Heart illustration with magnification of the artery.

copyright American Heart Association

Download (89.9 kB)

Heart with artery view — Heart with artery view

Heart illustration with magnification of the artery.

copyright American Heart Association

Download (89.9 kB)

Michael A. Portman, M.D., FAHA

Michael A. Portman, M.D., FAHA Director of research in the division of cardiology at Seattle Children’s Hospital and professor in the department of pediatrics at the University of Washington School of Medicine in Seattle, WA

copyright Seattle Children’s Hospital

Download (5.9 MB)

Michael A. Portman, M.D., FAHA — Michael A. Portman, M.D., FAHA

Michael A. Portman, M.D., FAHA Director of research in the division of cardiology at Seattle Children’s Hospital and professor in the department of pediatrics at the University of Washington School of Medicine in Seattle, WA

copyright Seattle Children’s Hospital

Download (5.9 MB)

American Heart Association Scientific Sessions Logo

copyright American Heart Association

Download (270.2 kB)

Related Video

Dr. Kim on SS22 316 Accessing Edoxaban safety in children

John S. Kim, M.D., a member of the American Heart Association’s Council on Lifelong Congenital Heart Disease and Heart Health in the Young and director of the Cardiac Thrombosis Management Program at the Heart Institute of the Children’s Hospital Colorado in Aurora, offers perspective on the news release - Anti-clotting pill may spare kids from frequent injections, blood tests, dietary changes - American Heart Association Scientific Sessions 2022, Abstract 316.

Transcript (txt)

copyright American Heart Association 2022

Download (61.1 MB)

Dr. Kim on SS22 316 Anti-clotting drugs and children

John S. Kim, M.D., a member of the American Heart Association’s Council on Lifelong Congenital Heart Disease and Heart Health in the Young and director of the Cardiac Thrombosis Management Program at the Heart Institute of the Children’s Hospital Colorado in Aurora, offers perspective on the news release - Anti-clotting pill may spare kids from frequent injections, blood tests, dietary changes - American Heart Association Scientific Sessions 2022, Abstract 316.

Transcript (txt)

copyright American Heart Association 2022

Download (58.6 MB)

Dr. Kim on SS22 316 Edoxaban dosing

John S. Kim, M.D., a member of the American Heart Association’s Council on Lifelong Congenital Heart Disease and Heart Health in the Young and director of the Cardiac Thrombosis Management Program at the Heart Institute of the Children’s Hospital Colorado in Aurora, offers perspective on the news release - Anti-clotting pill may spare kids from frequent injections, blood tests, dietary changes - American Heart Association Scientific Sessions 2022, Abstract 316.

Transcript (txt)

copyright American Heart Association 2022

Download (61.8 MB)

Dr. Kim on SS22 316 future treatment options

John S. Kim, M.D., a member of the American Heart Association’s Council on Lifelong Congenital Heart Disease and Heart Health in the Young and director of the Cardiac Thrombosis Management Program at the Heart Institute of the Children’s Hospital Colorado in Aurora, offers perspective on the news release - Anti-clotting pill may spare kids from frequent injections, blood tests, dietary changes - American Heart Association Scientific Sessions 2022, Abstract 316.

Transcript (txt)

copyright American Heart Association 2022

Download (78.2 MB)

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

CLOSE PROCEED